Xiong Yan, Patana Anne-Sisko, Miley Michael J, Zielinska Agnieszka K, Bratton Stacie M, Miller Grover P, Goldman Adrian, Finel Moshe, Redinbo Matt R, Radominska-Pandya Anna
Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
Drug Metab Dispos. 2008 Mar;36(3):517-22. doi: 10.1124/dmd.107.016469. Epub 2007 Nov 29.
All UDP-glucuronosyltransferase enzymes (UGTs) share a common cofactor, UDP-glucuronic acid (UDP-GlcUA). The binding site for UDP-GlcUA is localized to the C-terminal domain of UGTs on the basis of amino acid sequence homology analysis and crystal structures of glycosyltransferases, including the C-terminal domain of human UGT2B7. We hypothesized that the (393)DQMDNAK(399) region of human UGT1A10 interacts with the glucuronic acid moiety of UDP-GlcUA. Using site-directed mutagenesis and enzymatic analysis, we demonstrated that the D393A mutation abolished the glucuronidation activity of UGT1A10 toward all substrates. The effects of the alanine mutation at Q(394),D(396), and K(399) on glucuronidation activities were substrate-dependent. Previously, we examined the importance of these residues in UGT2B7. Although D(393) (D(398) in UGT2B7) is similarly critical for UDP-GlcUA binding in both enzymes, the effects of Q(394) (Q(399) in UGT2B7) to Ala mutation on activity were significant but different between UGT1A10 and UGT2B7. A model of the UDP-GlcUA binding site suggests that the contribution of other residues to cosubstrate binding may explain these differences between UGT1A10 and UGT2B7. We thus postulate that D(393) is critical for the binding of glucuronic acid and that proximal residues, e.g., Q(394) (Q(399) in UGT2B7), play a subtle role in cosubstrate binding in UGT1A10 and UGT2B7. Hence, this study provides important new information needed for the identification and understanding of the binding sites of UGTs, a major step forward in elucidating their molecular mechanism.
所有的尿苷二磷酸葡萄糖醛酸基转移酶(UGTs)都共用一个共同的辅因子,即尿苷二磷酸葡萄糖醛酸(UDP-GlcUA)。基于氨基酸序列同源性分析以及糖基转移酶的晶体结构,包括人UGT2B7的C末端结构域,UDP-GlcUA的结合位点定位于UGTs的C末端结构域。我们推测人UGT1A10的(393)DQMDNAK(399)区域与UDP-GlcUA的葡萄糖醛酸部分相互作用。通过定点诱变和酶促分析,我们证明D393A突变消除了UGT1A10对所有底物的葡萄糖醛酸化活性。Q(394)、D(396)和K(399)处丙氨酸突变对葡萄糖醛酸化活性的影响取决于底物。此前,我们研究了这些残基在UGT2B7中的重要性。尽管D(393)(UGT2B7中的D(398))在两种酶中对UDP-GlcUA结合同样至关重要,但Q(394)(UGT2B7中的Q(399))突变为丙氨酸对活性的影响在UGT1A10和UGT2B7之间虽显著但有所不同。UDP-GlcUA结合位点的模型表明,其他残基对共底物结合的贡献可能解释了UGT1A10和UGT2B7之间的这些差异。因此,我们推测D(393)对葡萄糖醛酸的结合至关重要,而近端残基,例如Q(394)(UGT2B7中的Q(399)),在UGT1A10和UGT2B7的共底物结合中起微妙作用。因此,本研究为鉴定和理解UGTs的结合位点提供了重要的新信息,这是阐明其分子机制的重要一步。